Case Study in Resuscitation: Can New Data Help Cambridge Heart?
This article was originally published in Start Up
Executive Summary
Studies show that Cambridge Heart's new diagnostic test for identifying patients who are at near to mid-term risk of sudden cardiac death is useful for sorting out patients who would best benefit from implantable cardioverter-defibrillators (ICDs). But is a clear link between ICDs, a major relatively new cardiac therapy, and a diagnostic test sufficient to enable the diagnostic's success?